Vα14iNKT cells promote liver pathology during adenovirus infection by inducing CCL5 production: Implications for gene therapy

Journal of Virology

Volumn 84, Issue 17, 2010, Pages 8520-8529

  Ajuebor, Maureen N ^a   Chen, Qingling ^a   Strieter, Robert M ^b   Adegboyega, Patrick A ^c   Aw, Tak Yee ^a  

^a LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

^c Louisiana State University Health Sciences Center at Shreveport   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES;

ADENOVIRUS INFECTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CYTOKINE PRODUCTION; FLOW CYTOMETRY; GENE THERAPY; HOST RESISTANCE; IMMUNE RESPONSE; IN VIVO STUDY; INNATE IMMUNITY; LIVER INJURY; LIVER TOXICITY; MALE; MOUSE; NATURAL KILLER T CELL; NONHUMAN; PATHOLOGY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; THYMUS; V ALPHA 14 INVARIANT NATURAL KILLER T CELL; VIRUS REPLICATION; ADENOVIRUS; ANIMAL; C57BL MOUSE; CELL CULTURE; FEMALE; GENETICS; IMMUNOLOGY; LIVER; METABOLISM; MOUSE MUTANT; PHYSIOLOGY; VIROLOGY;

ADENOVIRIDAE; MUS;

ADENOVIRIDAE; ADENOVIRIDAE INFECTIONS; ANIMALS; CELLS, CULTURED; CHEMOKINE CCL5; FEMALE; GENE THERAPY; LIVER; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NATURAL KILLER T-CELLS;

EID: 77956643984     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00605-10     Document Type: Article

References (42)

1. Ajuebor, M. N., A. I. Aspinall, F. Zhou, T. Le, Y. Yang, S. J. Urbanski, S. Sidobre, M. Kronenberg, C. M. Hogaboam, and M. G. Swain. 2005. Lack of chemokine receptor CCR5 promotes murine fulminant liver failure by preventing the apoptosis of activated CD1d-restricted NKT cells. J. Immunol. 174:8027-8037.
2. Ajuebor, M. N., Y. Jin, G. L. Gremillion, R. M. Strieter, Q. Chen, and P. A. Adegboyega. 2008. GammadeltaT cells initiate acute inflammation and injury in adenovirus-infected liver via cytokine-chemokine cross talk. J. Virol. 82: 9564-9576.
3. Ajuebor, M. N., and M. G. Swain. 2002. Role of chemokines and chemokine receptors in the gastrointestinal tract. Immunology 105:137-143. (Pubitemid 34146679)
4. Ajuebor, M. N., Z. Wondimu, C. M. Hogaboam, T. Le, A. E. Proudfoot, and M. G. Swain. 2007. CCR5 deficiency drives enhanced natural killer cell trafficking to and activation within the liver in murine T cell-mediated hepatitis. Am. J. Pathol. 170:1975-1988.
5. Belperio, J. A., M. D. Burdick, M. P. Keane, Y. Y. Xue, J. P. Lynch III, B. L. Daugherty, S. L. Kunkel, and R. M. Strieter. 2000. The role of the CC chemokine, RANTES, in acute lung allograft rejection. J. Immunol. 165: 461-472. (Pubitemid 30429540)
6. Boehm, U., T. Klamp, M. Groot, and J. C. Howard. 1997. Cellular responses to interferon-gamma. Annu. Rev. Immunol. 15:749-795.
7. Brutkiewicz, R. R. 2006. CD1d ligands: the good, the bad, and the ugly. J. Immunol. 177:769-775.
8. Carnaud, C., D. Lee, O. Donnars, S. H. Park, A. Beavis, Y. Koezuka, and A. Bendelac. 1999. Cross-talk between cells of the innate immune system: NKT cells rapidly activate NK cells. J. Immunol. 163:4647-4650. (Pubitemid 29501223)
9. Chiba, A., C. C. Dascher, G. S. Besra, and M. B. Brenner. 2008. Rapid NKT cell responses are self-terminating during the course of microbial infection. J. Immunol. 181:2292-2302.
10. Cui, J., T. Shin, T. Kawano, H. Sato, E. Kondo, I. Toura, Y. Kaneko, H. Koseki, M. Kanno, and M. Taniguchi. 1997. Requirement for Valpha14 NKT cells in IL-12-mediated rejection of tumors. Science 278:1623-1626. (Pubitemid 27516281)
11. Faunce, D. E., and J. Stein-Streilein. 2002. NKT cell-derived RANTES recruits APCs and CD8+ T cells to the spleen during the generation of regulatory T cells in tolerance. J. Immunol. 169:31-38.
12. Gardner, T. R., Q. Chen, Y. Jin, and M. N. Ajuebor. 2010. Toll-like receptor 3 ligand dampens liver inflammation by stimulating V{alpha}14 invariant natural killer T cells to negatively regulate {gamma}{delta}T cells. Am. J. Pathol. 176:1779-1789.
13. Gerard, C., and B. J. Rollins. 2001. Chemokines and disease. Nat. Immunol. 2:108-115.
14. Godfrey, D. I., H. R. MacDonald, M. Kronenberg, M. J. Smyth, and L. Van Kaer. 2004. NKT cells: what's in a name? Nat. Rev. Immunol. 4:231-237.
15. Gumperz, J. E., C. Roy, A. Makowska, D. Lum, M. Sugita, T. Podrebarac, Y. Koezuka, S. A. Porcelli, S. Cardell, M. B. Brenner, and S. M. Behar. 2000. Murine CD1d-restricted T cell recognition of cellular lipids. Immunity 12: 211-221.
16. Hildeman, D. A., T. Mitchell, J. Kappler, and P. Marrack. 2003. T cell apoptosis and reactive oxygen species. J. Clin. Invest. 111:575-581.
17. Hobbs, J. A., S. Cho, T. J. Roberts, V. Sriram, J. Zhang, M. Xu, and R. R. Brutkiewicz. 2001. Selective loss of natural killer T cells by apoptosis following infection with lymphocytic choriomeningitis virus. J. Virol. 75:10746-10754.
18. Kusters, S., F. Gantner, G. Kunstle, and G. Tiegs. 1996. Interferon gamma plays a critical role in T cell-dependent liver injury in mice initiated by concanavalin A. Gastroenterology 111:462-471. (Pubitemid 26256736)
19. Lee, A. H., J. H. Hong, and Y. S. Seo. 2000. Tumour necrosis factor-alpha and interferon-gamma synergistically activate the RANTES promoter through nuclear factor kappaB and interferon regulatory factor 1 (IRF-1) transcription factors. Biochem. J. 350:131-138.
20. Lin, A. A., P. K. Tripathi, A. Sholl, M. B. Jordan, and D. A. Hildeman. 2009. Gamma interferon signaling in macrophage lineage cells regulates central nervous system inflammation and chemokine production. J. Virol. 83:8604-8615.
21. Liu, Q., and D. A. Muruve. 2003. Molecular basis of the inflammatory response to adenovirus vectors. Gene Ther. 10:935-940. (Pubitemid 36722427)
22. Liu, Z. X., S. Govindarajan, and N. Kaplowitz. 2004. Innate immune system plays a critical role in determining the progression and severity of acetaminophen hepatotoxicity. Gastroenterology 127:1760-1774.
23. Liu, Z. X., S. Govindarajan, S. Okamoto, and G. Dennert. 2000. NK cells cause liver injury and facilitate the induction of T cell-mediated immunity to a viral liver infection. J. Immunol. 164:6480-6486.
24. Lozier, J. N., G. Csako, T. H. Mondoro, D. M. Krizek, M. E. Metzger, R. Costello, J. G. Vostal, M. E. Rick, R. E. Donahue, and R. A. Morgan. 2002. Toxicity of a first-generation adenoviral vector in rhesus macaques. Hum. Gene Ther. 13:113-124.
25. Matsuda, J. L., T. Mallevaey, J. Scott-Browne, and L. Gapin. 2008. CD1d-restricted iNKT cells, the 'Swiss-Army knife' of the immune system. Curr. Opin. Immunol. 20:358-368.
26. Matsuda, J. L., O. V. Naidenko, L. Gapin, T. Nakayama, M. Taniguchi, C. R. Wang, Y. Koezuka, and M. Kronenberg. 2000. Tracking the response of natural killer T cells to a glycolipid antigen using CD1d tetramers. J. Exp. Med. 192:741-754.
27. Metelitsa, L. S., H. W. Wu, H. Wang, Y. Yang, Z. Warsi, S. Asgharzadeh, S. Groshen, S. B. Wilson, and R. C. Seeger. 2004. Natural killer T cells infiltrate neuroblastomas expressing the chemokine CCL2. J. Exp. Med. 199:1213-1221.
28. Minagawa, M., H. Kawamura, Z. Liu, S. Govindarajan, and G. Dennert. 2005. Suppression of adenoviral gene expression in the liver: role of innate vs adaptive immunity and their cell lysis mechanisms. Liver Int. 25:622-632. (Pubitemid 40861912)
29. Muruve, D. A., M. J. Barnes, I. E. Stillman, and T. A. Libermann. 1999. Adenoviral gene therapy leads to rapid induction of multiple chemokines and acute neutrophil-dependent hepatic injury in vivo. Hum. Gene Ther. 10:965-976.
30. Nagarajan, N. A., and M. Kronenberg. 2007. Invariant NKT cells amplify the innate immune response to lipopolysaccharide. J. Immunol. 178:2706-2713. (Pubitemid 46335652)
31. Porubsky, S., A. O. Speak, B. Luckow, V. Cerundolo, F. M. Platt, and H. J. Grone. 2007. Normal development and function of invariant natural killer T cells in mice with isoglobotrihexosylceramide (iGb3) deficiency. Proc. Natl. Acad. Sci. U. S. A. 104:5977-5982.
32. Proudfoot, A. E., C. A. Power, A. J. Hoogewerf, M. O. Montjovent, F. Borlat, R. E. Offord, and T. N. Wells. 1996. Extension of recombinant human RANTES by the retention of the initiating methionine produces a potent antagonist. J. Biol. Chem. 271:2599-2603.
33. Raper, S. E., N. Chirmule, F. S. Lee, N. A. Wivel, A. Bagg, G. P. Gao, J. M. Wilson, and M. L. Batshaw. 2003. Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenoviral gene transfer. Mol. Genet. Metab. 80:148-158.
34. Speak, A. O., M. Salio, D. C. Neville, J. Fontaine, D. A. Priestman, N. Platt, T. Heare, T. D. Butters, R. A. Dwek, F. Trottein, M. A. Exley, V. Cerundolo, and F. M. Platt. 2007. Implications for invariant natural killer T cell ligands due to the restricted presence of isoglobotrihexosylceramide in mammals. Proc. Natl. Acad. Sci. U. S. A. 104:5971-5976.
35. Taniguchi, M., K. Seino, and T. Nakayama. 2003. The NKT cell system: bridging innate and acquired immunity. Nat. Immunol. 4:1164-1165.
36. Tyznik, A. J., E. Tupin, N. A. Nagarajan, M. J. Her, C. A. Benedict, and M. Kronenberg. 2008. The mechanism of invariant NKT cell responses to viral danger signals. J. Immunol. 181:4452-4456.
37. Vlahakis, S. R., A. Villasis-Keever, T. S. Gomez, G. D. Bren, and C. V. Paya. 2003. Human immunodeficiency virus-induced apoptosis of human hepatocytes via CXCR4. J. Infect. Dis. 188:1455-1460.
38. Wesley, J. D., M. S. Tessmer, D. Chaukos, and L. Brossay. 2008. NK cell-like behavior of Valpha14i NK T cells during MCMV infection. PLoS Pathog. 4:e1000106.
39. Wilson, J. M. 1996. Adenoviruses as gene-delivery vehicles. N. Engl. J. Med. 334:1185-1187.
40. Yang, X., P. Lu, C. Fujii, Y. Nakamoto, J. L. Gao, S. Kaneko, P. M. Murphy, and N. Mukaida. 2006. Essential contribution of a chemokine, CCL3, and its receptor, CCR1, to hepatocellular carcinoma progression. Int. J. Cancer 118:1869-1876.
41. Yang, Y., H. C. Ertl, and J. M. Wilson. 1994. MHC class I-restricted cytotoxic T lymphocytes to viral antigens destroy hepatocytes in mice infected with E1-deleted recombinant adenoviruses. Immunity 1:433-442. (Pubitemid 2134473)
42. Zhang, Y., and J. M. Bergelson. 2005. Adenovirus receptors. J. Virol. 79: 12125-12131.